The response of dicumarol-induced hypoprothrombinemia to vitamin K.
作者信息
REHBEIN A, JARETZKI A, HABIF D V
出版信息
Ann Surg. 1952 Apr;135(4):454-69. doi: 10.1097/00000658-195204000-00003.
Abstract
摘要
相似文献
1
The response of dicumarol-induced hypoprothrombinemia to vitamin K.双香豆素诱导的低凝血酶原血症对维生素K的反应。
Ann Surg. 1952 Apr;135(4):454-69. doi: 10.1097/00000658-195204000-00003.
2
3
Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.维生素K制剂对双香豆素和曲美香豆素所致低凝血酶原血症的作用。
Br Med J. 1952 Feb 23;1(4755):412-5. doi: 10.1136/bmj.1.4755.412.
4
Hypoprothrombinemia in biliary fistula dogs induced by minute doses of dicumarol.小剂量双香豆素诱发胆瘘犬低凝血酶原血症。
Am J Physiol. 1952 Feb;168(2):287-91. doi: 10.1152/ajplegacy.1952.168.2.287.
5
Vitamin K1 in treatment of bishydroxycoumarin-induced hypoprothrombinemia; comparison of intravenous and intramuscular administration.维生素K1治疗双香豆素诱导的低凝血酶原血症；静脉注射与肌肉注射的比较
J Am Med Assoc. 1956 Jul 21;161(12):1145-7. doi: 10.1001/jama.1956.02970120027008.
6
The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia.维生素K水溶性制剂在双香豆素诱导的低凝血酶原血症中的作用。
N Engl J Med. 1950 Nov 16;243(20):775-9. doi: 10.1056/NEJM195011162432004.
7
[Effects of vitamine K 1 on hypoprothrombinemia caused by dicumarol and on the acceleration factors in the rabbit with liver damage and the hepatectomized cat].[维生素K1对双香豆素所致低凝血酶原血症以及对肝损伤家兔和肝切除猫的加速因子的影响]
Acta Haematol. 1952 Mar;7(3):143-56. doi: 10.1159/000204047.
8
Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia.合成水溶性维生素K制剂在双香豆素诱导的低凝血酶原血症中的有效性。
J Am Med Assoc. 1951 Feb 10;145(6):393-9. doi: 10.1001/jama.1951.02920240029008.
9
Dihydrovitamin Kl biphosphate in bishydroxycoumarin induced hypoprothrombinemia.双香豆素诱导的低凝血酶原血症中的二氢维生素K1二磷酸酯
J Lab Clin Med. 1960 Jul;56:21-4.
10
Intravenous emulsified vitamin K in the treatment of coumarin-induced hypoprothrombinemia.静脉注射乳化维生素K治疗香豆素诱导的低凝血酶原血症。
Am Heart J. 1952 Jul;44(1):124-30. doi: 10.1016/0002-8703(52)90180-4.
引用本文的文献
1
Vitamin K1 in the control of phenylindanedione-induced anticoagulant therapy.维生素K1在苯茚二酮诱导的抗凝治疗中的应用
Can Med Assoc J. 1955 Feb 1;72(3):184-5.
2
The current status of the treatment of coronary heart disease.冠心病的治疗现状。
Can Med Assoc J. 1953 Feb;68(2):95-103.
本文引用的文献
1
THE SYNTHESIS OF VITAMIN K1.维生素K1的合成
Science. 1940 Jan 12;91(2350):31-6. doi: 10.1126/science.91.2350.31.
2
Preliminary report on the clinical use of a new anticoagulant, phenylindandione.新型抗凝剂苯茚二酮临床应用的初步报告
Circulation. 1950 May;1(5):1195-1204. doi: 10.1161/01.cir.1.5.1195.
3
A new prothrombopenic drug, phenylindanedione.
Can Med Assoc J. 1950 May;62(5):465-70.
4
Major bleeding resulting from a single dose of dicumarol.单剂量双香豆素引起的严重出血。
Ann Intern Med. 1950 Apr;32(4):731-5. doi: 10.7326/0003-4819-32-4-731.
5
Antagonism of dicumarol by vitamin K preparations.维生素K制剂对双香豆醇的拮抗作用。
N Engl J Med. 1950 Feb 9;242(6):211-5. doi: 10.1056/NEJM195002092420604.
6
The effects of 4 hydroxycoumarin anticoagulant No. 63 upon the prothrombin time in dogs and human beings.4-羟基香豆素抗凝剂63号对犬和人凝血酶原时间的影响。
J Lab Clin Med. 1950 Jan;35(1):8-15.
7
Clinical tests of a new coumarin substance; a report to the Medical Research Council.一种新型香豆素物质的临床试验；提交给医学研究委员会的报告。
Br Med J. 1949 Dec 3;2(4639):1250-4. doi: 10.1136/bmj.2.4639.1250.
8
The treatment of dicumarol-induced hypoprothrombinemia in man with emulsified vitamin K1 administered intravenously.静脉注射乳化维生素K1治疗人香豆素诱导的低凝血酶原血症。
J Lab Clin Med. 1951 Feb;37(2):269-71.
9
Tromexan-3,3'-carboxymethylenebis (4-hydroxycoumarin) ethyl ester; experimental and clinical properties.曲美新-3,3'-亚甲基双（4-羟基香豆素）乙酯；实验和临床特性
Circulation. 1951 Feb;3(2):164-70. doi: 10.1161/01.cir.3.2.164.
10
Effectiveness of synthetic water-soluble vitamin K preparations in bishydroxycoumarin-induced hypoprothrombinemia.合成水溶性维生素K制剂在双香豆素诱导的低凝血酶原血症中的有效性。
J Am Med Assoc. 1951 Feb 10;145(6):393-9. doi: 10.1001/jama.1951.02920240029008.
Zotero 插件